Posted by Frank Tan > 2020-07-16 16:16 | Report Abuse

wah lou..red sea last no see...

Posted by CKNG8291 > 2020-07-16 16:17 | Report Abuse

all throw glove and go pharmacy counter....

Posted by longtermvaluegain > 2020-07-16 19:08 | Report Abuse

EPF 都是看见Dpharma for long term.

Posted by stockraider > 2020-07-16 19:08 | Report Abuse

What is your action on TOP GLOVE? (1) Buy More (2) Sell (3) Do Nothing
Author: gloveharicut | Publish date: Thu, 16 Jul 2020, 6:33 PM

What is your action on TOP GLOVE?

(1) Buy More

(2) Sell

(3) Do Nothing

(4) Start praying



I invite you to read my blog and make a smart decision. Leave a comment in my post if you would like to share your action.

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp



Thank you.

Posted by secretinvestor8888 > 2020-07-16 19:47 | Report Abuse

.

UNCLE SECRET IS BACK!!!

B U Y:

TOPGLOV-HA
SUPERMX
KOSSAN

S E L L:

COMFORT
TOPGLOV

Posted by Man62 > 2020-07-17 08:26 | Report Abuse

This is safe haven stock after gloves.

Posted by EatCoconutCanWin > 2020-07-17 08:29 | Report Abuse

sell before too late..

Posted by zack71 > 2020-07-17 08:40 | Report Abuse

this stock like glove stock be4 pandemic supermax only rm1.70 now rm17 dpharma only show after vaksin coming opportunity for investor

Posted by turtleking > 2020-07-17 09:12 | Report Abuse

buy before too late

Posted by themonstik > 2020-07-17 12:42 | Report Abuse

no gas at all..

Posted by Takers > 2020-07-17 13:13 | Report Abuse

https://www.trtworld.com/magazine/a-covid-19-vaccine-by-september-oxford-researchers-optimistic-38164/amp

Posted by t_nike2002 > 2020-07-17 14:44 | Report Abuse

Silly to sell this stock....

Posted by t_nike2002 > 2020-07-17 14:45 | Report Abuse

There would be breather day.... don't worry... steady stock

Posted by Takers > 2020-07-17 14:46 | Report Abuse

Heavy selling on this counter, gloves still popular at the moment

Posted by investory321 > 2020-07-17 15:05 | Report Abuse

tolong sell down to 1.60 again, last round not yet buy enough already jump up

Posted by stocktrade101 > 2020-07-17 15:47 | Report Abuse

interesting...

Posted by stocktrade101 > 2020-07-17 16:09 | Report Abuse

https://www.globaltimes.cn/content/1194728.shtml

Hopefully Dpharma is working with Sinopharm to bring their vaccine to Malaysia. Getting close.

Posted by Xcalibre > 2020-07-17 17:03 | Report Abuse

Yea opportunity to buy if down...

Posted by kiangloon > 2020-07-17 17:34 | Report Abuse

I stuck at level 1.99

Posted by stocktrade101 > 2020-07-17 18:54 | Report Abuse

one good news about cooperating with a named foreign company to package the vaccines will send dpharma to the sky.

Posted by geary > 2020-07-17 20:00 | Report Abuse

Chinese vaccine candidate effective against all known coronavirus strains: Sinopharm
By Fan Wei Source: Global Times Published: 2020/7/16 16:20:26
15
We are racing with the virus, not the US: Sinopharm president

A Chinese-developed inactivated COVID-19 vaccine candidate is effective against all detected strains of the virus so far, with lower chance and degree of adverse reactions than same-typed vaccine candidates under research, the head of the vaccine candidate's producer told the Global Times in an exclusive interview on Monday.

"The inactivated vaccine we developed can cover all strains of the coronavirus that have been detected so far, including the virus strains tracked in the Xinfadi market in Beijing," Yang Xiaoming, president of China National Pharmaceutical Group (Sinopharm), noted in response to public concerns that the vaccine under the R&D process would be ineffective as the virus mutates.

The research team has carried out cross-protection experiments to test if the anti-serum obtained by immunizing animals can produce an immune response to different genotypes of strains of coronavirus, Yang said.

Sinopharm, whose COVID-19 inactivated vaccine candidates have been delivered into phase three clinical trials, have stored more than 4 million doses of the vaccines, the Global Times learned from the group.

Yang said that the group is currently storing more COVID-19 vaccines. Once a candidate is approved for the market, the company will soon be able to provide as many doses of vaccines as the country needs.

Yang estimated that an inactivated COVID-19 vaccine will be available on the market at the end of this year or early 2021. Two inactivated COVID-19 vaccine candidates separately developed by Sinopharm institutes in Beijing and Wuhan entered clinical trials in April.

The results of phase one and two clinical trials of the two candidates were revealed in June, showing that all receptors have created high-titer antibodies.

Skepticism and pessimism of Chinese-developed COVID-19 vaccines have been raised in some Western media, which have exaggerated the side effect ratio reported in early-stage clinical trials of another vaccine candidate, the Ad5-nCoV recombinant novel coronavirus vaccine.

Vaccine experts advised the public not to panic over the side effects revealed in the preliminary results of the Chinese-developed coronavirus vaccine, as the adverse reactions exposed are tolerable and the vaccine is under constant optimization.

Yang also reveals that more than 1,000 Sinopharm group employees have been receiving injections on a voluntary basis, and the results show a promising trend that the vaccine is safe and effective, with low incidence and degree of adverse reactions.

At the end of May, 180 volunteers from Sinopharm received inactivated COVID-19 vaccinations, and their antibodies have reached levels resistant to the coronavirus with a 100 percent protective rate.

On June 23, Sinopharm signed agreements with the United Arab Emirates (UAE) government to conduct COVID-19 vaccine candidate phase three clinical trials in the country, the world's first COVID-19 vaccine candidate phase three clinical trials to have been launched.

China's National Medical Products Administration on Thursday stressed the need to promote the development and marketing of COVID-19 vaccines, and take the initiative to help pharmaceutical companies resume work and production.

As China and the US have been given great hopes on providing panacea for the coronavirus, their respective vaccine R&D pace has drawn much media attention. Some have called the vaccine development "a race between two countries currently caught in strained ties."

Leading US medical expert Anthony Fauci expressed his confidence in prospects for the US vaccine on Wednesday, and said he does not expect China to win the vaccine race, Reuters reported.

"The COVID war between the US and China is looking like a race to the moon. Being first to develop COVID treatments and vaccines has become a point of national pride," Lawrence Gostin, the director of Georgetown University's O'Neill Institute for National and Global Health Law, was quoted as saying in the report of Business Insider. "A 'my country first' attitude is highly counterproductive. We need to work cooperatively as a global and scientific community."

"We are racing with the coronavirus but not with the US [to be the first with successful vaccine]", Yang argued, claiming that all their efforts are part of China's commitment to make the vaccine available to the international community.

Yang said he hopes to see Chinese-developed vaccines against coronavirus accessible and affordable for developing countries when they turn out. He expects further global cooperation in COVID-19 vaccine trials to help stop the pandemic that has infected millions.

Posted by mf > 2020-07-17 20:02 |

Post removed.Why?

Posted by geary > 2020-07-17 20:10 | Report Abuse

Covid19 Vaccine in September.

British pharma giant AstraZeneca is "on track" to begin rolling out up to two billion doses of a coronavirus vaccine in September if ongoing trials prove successful, its chief executive said on Friday.

The company is partnering with Oxford University, which has pioneered the vaccine, and is already manufacturing doses before seeking final regulatory approval once testing concludes in the coming months.

"So far we're still on track... we are starting to manufacture this vaccine right now, and we have to have it ready to be used by the time we have the results," AstraZeneca chief executive Pascal Soriot told BBC radio.

"Our present assumption is that we will have the data by the end of the summer, by August, so in September we should know whether we have an effective vaccine or not."

The firm announced this week it had struck agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India to double production capacity of the COVID-19 vaccine to two billion doses.

The partnership with the Indian institute—one of the world's largest vaccine manufacturers—will help supply it to a large number of low- and middle-income countries.

AstraZeneca has established separate supply chains for the vaccine in Europe, the United States, India and is also looking at setting up production in China, Soriot said.

He added AstraZeneca, which is undertaking the work on a non-profit basis, could lose money if trials prove disappointing.

But he said the company was sharing the financial risk with organisations such as CEPI.

"We're manufacturing indeed at risk—and that's the only way to have the vaccine ready to go if it works," he added.

Oxford University began initial trials of its COVID-19 vaccine with hundreds of volunteers in April, and is now expanding them to 10,000 participants.

It said last month they were "progressing very well".

Researchers announced this week they will also start tests in mid-June in Brazil, the first country outside Britain to take part in the study, as the South American country's virus infection rate spirals while the UK's falls.

Posted by HowAh > 2020-07-17 21:59 | Report Abuse

How come no research report on this co?

Posted by jutaone88 > 2020-07-17 22:20 | Report Abuse

YB Khairy Jamaluddin, Menteri Sains, Teknologi, dan Inovasi hari ini menyaksikan sesi menandatangani dan pertukaran Memorandum Persefahaman (MoU) tiga pihak antara VentureTECH, DuoPharma Biotech Bhd (DuoPharma Biotech) dan PanGen Biotech Inc. (PanGen) ke arah penubuhan kemudahan fasiliti biosimilar yang pertama di Malaysia.
.
"Saya percaya MoU strategik dan kerjasama antarabangsa dalam pasaran biofarmaseutikal dapat memacu pertumbuhan industri bioteknologi di Malaysia, kerana Kementerian menetapkan bioteknologi sebagai ejen pertumbuhan utama ekonomi Malaysia" kata YB Khairy Jamaluddin.
.
YB Khairy menambah “Kerajaan memainkan peranan yang aktif dalam memajukan penjagaan kesihatan dan mempromosikan penggunaan teknologi, bekerjasama dengan industri untuk meningkatkan kualiti hidup dan akses kepada penjagaan kesihatan dengan menjadikannya berpatutan dan lebih mudah diakses oleh masyarakat. "
.
Dengan temeterainya MoU ini, VentureTech akan melabur RM15 juta untuk usaha sama antara Duopharma Biotech, sebuah syarikat farmaseutikal terkemuka di Malaysia dan PanGen, sebuah syarikat yang berpusat di Korea Selatan yang mengkhusus dalam penyelidikan dan pembuatan ubat-ubatan berasaskan bio bagi menghasilkan ubat-ubatan biosimilar untuk memenuhi pasaran domestik dan eksport .
.
Pembangunan industri biosimilar adalah sejajar dengan aspirasi Malaysia untuk membangunkan industri bioteknologi sebagai pemangkin ke arah menjadikan Malaysia negara berpendapatan tinggi yang berteraskan teknologi dan bernilai tambah tinggi.
.
Pembangunan industri biosimilar ini juga akan mengembangkan aktiviti pembuatan nasional ke arah yang lebih sofistikated, sekaligus menyediakan peluang pekerjaan berkemahiran tinggi dan berpendapatan tinggi dalam bidang bioteknologi melalui pemindahan teknologi serta pembangunan kapasiti dan keupayaan industri tempatan.
.
Di samping itu, penglibatan dalam pembuatan biosimilar ini juga bertujuan membangunkan bekalan rantaian nilai ubat-ubatan yang stabil bagi menjana pengganda sosioekonomi kepada masyarakat umum termasuk golongan B40 dalam konteks penyediaan bekalan
ubat-ubatan dengan harga yang lebih berpatutan khususnya bagi penyakit-penyakit kronik yang semakin meningkat di negara ini.
.
Biosimilar berkembang di pasaran secara global, dengan Asia Pasifik dijangka mewakili 32.8% pasaran pada tahun 2027, yang terbesar setelah pasaran Eropah.

.
#mosti
#STI

Posted by longtermvaluegain > 2020-07-18 07:15 | Report Abuse

很多时候research houses 都是过后才真真发觉到/察觉到。

Posted by longtermvaluegain > 2020-07-18 08:39 | Report Abuse

英文版:
https://www.theedgemarkets.com/article/malaysia-set-have-first-biosimilar-production-facility-2024

Posted by chopstick > 2020-07-18 09:04 | Report Abuse

JV with korea production by 2024, haha by the time everyone oledi vaccinated. maybe keep it for future pandemic. buying bulk to rebottling , talking like school kid beh tahan

Posted by stocktrade101 > 2020-07-18 09:06 | Report Abuse

It is a good thing medicines can be produced in volumn locally.

Posted by wwg2 > 2020-07-18 09:35 | Report Abuse

没发现越来越多疫苗的新闻了？　呵呵

Posted by chopstick > 2020-07-18 09:39 | Report Abuse

@wwg2 , not all investor are chinese la, share it to all malaysian.

Posted by cyclops80 > 2020-07-18 11:20 | Report Abuse

and not all chinese know how to read and write in chinese

Posted by longtermvaluegain > 2020-07-18 12:21 | Report Abuse

Beh tahan? Aku tengok Supermx,.Topglov pun beh tahan . Bodohnya dan lembapnya Aku untuk beli dan simpan Supermx, Harta, Kossan, Topglov pada bulan April.2020 ini.

Posted by AlexZai > 2020-07-18 12:36 | Report Abuse

i feel u longterm value. the polarization runs too deep.
rich gets richer T.T

Posted by AlexZai > 2020-07-18 12:37 | Report Abuse

Dpharma would be the next Topglov. The tides is changing soon

Posted by chopstick > 2020-07-18 12:59 | Report Abuse

i guess many got stuck , REMEMBER ONE GOLDEN RULE "buy on rumours, sell on news."or buy after news , sell on rumours

Posted by stockraider > 2020-07-18 19:57 | Report Abuse

Just buy lah...!!

Very steady company mah..!

Posted by AlexZai > 2020-07-18 22:37 | Report Abuse

Y and me.. siao meh.. haha after four years
Agree with stockraider... we should look forward to it. It is a company with great potentials.. esp it tapping into production of biosimilars

Posted by longtermvaluegain > 2020-07-19 07:15 | Report Abuse

Dpharma perhaps gap up tomorrow or limit up.

Posted by stocktrade101 > 2020-07-19 09:08 | Report Abuse

I like the part that dpharma can and will be able to produce biosimilar medicines for cancers, diabetes, hiv, hcv, etc.,plus of course different types of vaccines. Should be a lucratic business.

Posted by profitgrow > 2020-07-20 10:09 | Report Abuse

drop like hell.. run run run...

Posted by Takers > 2020-07-20 10:17 | Report Abuse

no news = will be in sleeping mode for a while! Waiting for more good news to come

Posted by profitgrow > 2020-07-20 10:19 | Report Abuse

sell. before its too late

Posted by profitgrow > 2020-07-20 10:20 | Report Abuse

everyday drop 1-2%.. enough to kill your money.

Posted by chshzhd > 2020-07-20 11:10 | Report Abuse

steady ..

Posted by profitgrow > 2020-07-20 11:19 | Report Abuse

faster sell before too late. it will drop because no vaccine yet. all still testing haha

Posted by Thelastone > 2020-07-20 12:12 | Report Abuse

Buy when it is low to prepare for vaccine come!
More than 100vaccines in development sure a few will be successful to help save human race from the onslaught of covid-19 which so far have killed more than 600k people.Have faith in Science and Tech.

Posted by profitgrow > 2020-07-20 12:28 | Report Abuse

sell. because vaccine still long way to come, now over valued already.

Posted by Thelastone > 2020-07-20 12:44 | Report Abuse

Not long but short.As short as 2 months by this September’20 for AstraZeneca-Uni Oxford,Moderna and Sinopharm to complete their phase 3 human trials!

Posted by EliteYY69 > 2020-07-20 13:01 | Report Abuse

vaccine is coming soon, if u sell, i confirm u miss the good chance.